<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wu JR</submitter><funding>Taipei Medical University</funding><pagination>2</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12764038</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Opioid-related oversedation is associated with respiratory depression and can lead to potentially catastrophic adverse events in hospitalized patients. This study aimed to investigate influential factors for postoperative sedation during morphine-based intravenous patient-controlled analgesia (IV-PCA).&lt;h4>Methods&lt;/h4>We enrolled patients who received morphine-based IV-PCA for postoperative pain at a medical hospital between January 2020 and November 2022. The primary outcome was unintentional sedation within 72 h after surgery. The Observer Assessment of Alertness/Sedation Scale (OAA/S) was used to assess the sedation depth at 12-hour intervals. Multivariable logistic regression models were used to calculate the adjusted odds ratio (aOR) with 95% confidence interval (CI)</pubmed_abstract><journal>BMC anesthesiology</journal><pubmed_title>Risk factors for morphine-associated sedation in intravenous patient-controlled analgesia for postoperative pain.</pubmed_title><pmcid>PMC12764038</pmcid><funding_grant_id>TMU110-AE1-B11</funding_grant_id><pubmed_authors>Wu JR</pubmed_authors><pubmed_authors>Chen JT</pubmed_authors><pubmed_authors>Wu HL</pubmed_authors><pubmed_authors>Wu YM</pubmed_authors><pubmed_authors>Cata JP</pubmed_authors><pubmed_authors>Cherng YG</pubmed_authors><pubmed_authors>Tai YH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk factors for morphine-associated sedation in intravenous patient-controlled analgesia for postoperative pain.</name><description>&lt;h4>Background&lt;/h4>Opioid-related oversedation is associated with respiratory depression and can lead to potentially catastrophic adverse events in hospitalized patients. This study aimed to investigate influential factors for postoperative sedation during morphine-based intravenous patient-controlled analgesia (IV-PCA).&lt;h4>Methods&lt;/h4>We enrolled patients who received morphine-based IV-PCA for postoperative pain at a medical hospital between January 2020 and November 2022. The primary outcome was unintentional sedation within 72 h after surgery. The Observer Assessment of Alertness/Sedation Scale (OAA/S) was used to assess the sedation depth at 12-hour intervals. Multivariable logistic regression models were used to calculate the adjusted odds ratio (aOR) with 95% confidence interval (CI)</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-06T10:32:19.425Z</modification><creation>2026-05-29T03:11:53.579Z</creation></dates><accession>S-EPMC12764038</accession><cross_references><pubmed>41286757</pubmed><doi>10.1186/s12871-025-03520-1</doi></cross_references></HashMap>